Rheumatoid arthritis and cardiovascular disease

被引:244
|
作者
Crowson, Cynthia S. [1 ]
Liao, Katherine P. [2 ,3 ]
Davis, John M., III [1 ]
Solomon, Daniel H. [2 ,3 ]
Matteson, Eric L. [1 ]
Knutson, Keith L. [1 ]
Hlatky, Mark A. [4 ]
Gabriel, Sherine E. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
IMPROVES ENDOTHELIAL FUNCTION; NONCARDIAC VASCULAR-DISEASE; T-CELLS; GASTROINTESTINAL TOXICITY; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; ARTERIAL STIFFNESS; TELOMERIC LOSS; HEART-FAILURE; LIPID PROFILE;
D O I
10.1016/j.ahj.2013.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Rheumatic disease and heart disease share common underpinnings involving inflammation. The high levels of inflammation that characterize rheumatic diseases provide a "natural experiment" to help elucidate the mechanisms by which inflammation accelerates heart disease. Rheumatoid arthritis (RA) is the most common of the rheumatic diseases and has the best studied relationships with heart disease. Methods A review of current literature on heart disease and RA was conducted. Results Patients with RA have an increased risk of developing heart disease that is not fully explained by traditional cardiovascular risk factors. Therapies used to treat RA may also affect the development of heart disease; by suppressing inflammation, they may also reduce the risk of heart disease. However, their other effects, as in the case of steroids, may increase heart disease risk. Conclusions Investigations of the innate and adaptive immune responses occurring in RA may delineate novel mechanisms in the pathogenesis of heart disease and help identify novel therapeutic targets for the prevention and treatment of heart disease.
引用
收藏
页码:622 / +
页数:8
相关论文
共 50 条
  • [1] Cardiovascular disease in rheumatoid arthritis
    Gonzalez-Gay, Miguel A.
    Gonzalez-Juanatey, Carlos
    Miranda-Filloy, Jose A.
    Garcia-Porrua, Carlos
    Llorca, Javier
    Martin, Javier
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (10) : 673 - 677
  • [2] Cardiovascular disease in rheumatoid arthritis
    Kaplan, Mariana J.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (03) : 289 - 297
  • [3] Rheumatoid arthritis and cardiovascular disease
    Saurabh S. Dhawan
    Arshed A. Quyyumi
    [J]. Current Atherosclerosis Reports, 2008, 10 : 128 - 133
  • [4] Rheumatoid arthritis: A cardiovascular disease?
    Daien, C. I.
    Fesler, P.
    [J]. ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 2012, 61 (02): : 111 - 117
  • [5] Rheumatoid Arthritis and Cardiovascular Disease
    Dhawan, Saurabh S.
    Quyyumi, Arshed A.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2008, 10 (02) : 128 - 133
  • [6] Rheumatoid arthritis and cardiovascular disease
    Wasko M.C.M.
    [J]. Current Rheumatology Reports, 2008, 10 (5) : 390 - 397
  • [7] Cardiovascular Disease in Rheumatoid Arthritis
    Sen, Deepali
    Gonzalez-Mayda, Maria
    Brasington, Richard D., Jr.
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2014, 40 (01) : 27 - +
  • [8] Extent of cardiovascular disease in rheumatoid arthritis
    Kitas, GD
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 52 - 52
  • [9] Atherosclerosis and cardiovascular disease in rheumatoid arthritis
    Szekanecz, Z.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126
  • [10] Prevention of cardiovascular disease in rheumatoid arthritis
    Hollan, I.
    Dessein, P. H.
    Ronda, N.
    Wasko, M. C.
    Svenungsson, E.
    Agewall, S.
    Cohen-Tervaert, J. W.
    Maki-Petaja, K.
    Grundtvig, M.
    Karpouzas, G. A.
    Meroni, P. L.
    [J]. AUTOIMMUNITY REVIEWS, 2015, 14 (10) : 952 - 969